Literature DB >> 15035966

Trials of immunotherapy to preserve beta-cell function of prediabetic and new-onset patient trials.

George S Eisenbarth1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15035966     DOI： 10.1007/s11892-004-0061-1

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


× No keyword cloud information.
  4 in total

1.  Guidelines for intervention trials in subjects with newly diagnosed type 1 diabetes.

Authors:  Carla J Greenbaum; Leonard C Harrison
Journal:  Diabetes       Date:  2003-05       Impact factor: 9.461

2.  Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.

Authors: 
Journal:  Ann Intern Med       Date:  1998-04-01       Impact factor: 25.391

3.  Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies.

Authors:  C F Verge; R Gianani; E Kawasaki; L Yu; M Pietropaolo; R A Jackson; H P Chase; G S Eisenbarth
Journal:  Diabetes       Date:  1996-07       Impact factor: 9.461

4.  Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes.

Authors:  Jeffrey P Krischer; David D Cuthbertson; Liping Yu; Tihamer Orban; Noel Maclaren; Richard Jackson; William E Winter; Desmond A Schatz; Jerry P Palmer; George S Eisenbarth
Journal:  J Clin Endocrinol Metab       Date:  2003-01       Impact factor: 5.958
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.